T-Cell Project: Epidemiologic Component
|ClinicalTrials.gov Identifier: NCT00705809|
Recruitment Status : Completed
First Posted : June 26, 2008
Last Update Posted : July 2, 2017
- The T-Cell Project, sponsored by the International T-cell non-Hodgkin Lymphoma Study Group, is a consortium of institutions interested in achieving more detailed information on clinical and biological characteristics of T-cell lymphomas.
- The T-Cell Project serves as a repository for data on patients with peripheral T-cell lymphoma (PTCL) worldwide. Its overall goal is to improve T-cell subtype classifications and evaluate treatment strategies for each subtype.
-To implement a standardized epidemiologic questionnaire into the ongoing T-Cell Project to allow evaluation of various potential risk factors for PTLCs.
-Untreated patients 18 years of age and older who were diagnosed with PTLC September 1, 2006, or later.
-Patients complete a questionnaire containing the following information:
Smoking history and alcohol use
Personal history or cancer
History of cancer among first-degree relatives
History of transplants
History of blood transfusions
Occupational and residential history
-The information collected is linked to clinical and pathologic information in the T-Cell Project database.
|Condition or disease|
|Peripheral T-Cell Lymphoma|
|Study Type :||Observational|
|Estimated Enrollment :||800 participants|
|Official Title:||T-Cell Project: Epidemiologic Component|
|Study Start Date :||June 18, 2008|
|Estimated Study Completion Date :||July 20, 2011|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00705809
|United States, Maryland|
|National Cancer Institute (NCI), 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|